Follow
Shaker Mousa
Shaker Mousa
President, Vascular Vision Pharmaceuticals Co
Verified email at vvpharma.com
Title
Cited by
Cited by
Year
Non-small cell lung cancer: current treatment and future advances
C Zappa, SA Mousa
Translational lung cancer research 5 (3), 288, 2016
17482016
Omega-3 fatty acids EPA and DHA: health benefits throughout life
D Swanson, R Block, SA Mousa
Advances in nutrition 3 (1), 1-7, 2012
16772012
Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin
S Kim, K Bell, SA Mousa, JA Varner
The American journal of pathology 156 (4), 1345-1362, 2000
8512000
Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis
JJ Bergh, HY Lin, L Lansing, SN Mohamed, FB Davis, S Mousa, PJ Davis
Endocrinology 146 (7), 2864-2871, 2005
6762005
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge, P Debourdeau, M Beckers, C Baglin, RM Bauersachs, B Brenner, ...
Journal of Thrombosis and Haemostasis 11 (1), 56-70, 2013
6712013
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer
Z Chen, PS Malhotra, GR Thomas, FG Ondrey, DC Duffey, CW Smith, ...
Clinical cancer research 5 (6), 1369-1379, 1999
6071999
The role of angiogenesis in cancer treatment
M Rajabi, SA Mousa
Biomedicines 5 (2), 34, 2017
5962017
Emerging nanopharmaceuticals
WE Bawarski, E Chidlowsky, DJ Bharali, SA Mousa
Nanomedicine: Nanotechnology, Biology and Medicine 4 (4), 273-282, 2008
5322008
Biosensors: the new wave in cancer diagnosis
B Bohunicky, SA Mousa
Nanotechnology, science and applications, 1-10, 2010
4982010
Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers
DJ Bharali, M Khalil, M Gurbuz, TM Simone, SA Mousa
International journal of nanomedicine, 1-7, 2009
4232009
Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate
IA Siddiqui, VM Adhami, DJ Bharali, BB Hafeez, M Asim, SI Khwaja, ...
Cancer research 69 (5), 1712-1716, 2009
4142009
Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library
KT O'Neil, RH Hoess, SA Jackson, NS Ramachandran, SA Mousa, ...
Proteins: Structure, Function, and Bioinformatics 14 (4), 509-515, 1992
4051992
Apoptosis and acute brain ischemia in ischemic stroke
D Radak, N Katsiki, I Resanovic, A Jovanovic, E Sudar-Milovanovic, ...
Current vascular pharmacology 15 (2), 115-122, 2017
3922017
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer
P Debourdeau, D Farge, M Beckers, C Baglin, RM Bauersachs, B Brenner, ...
Journal of Thrombosis and Haemostasis 11 (1), 71-80, 2013
3642013
Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases
A Trpkovic, I Resanovic, J Stanimirovic, D Radak, SA Mousa, ...
Critical reviews in clinical laboratory sciences 52 (2), 70-85, 2015
3622015
l-Thyroxine vs. 3,5,3′-triiodo-l-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
HY Lin, M Sun, HY Tang, C Lin, MK Luidens, SA Mousa, S Incerpi, ...
American Journal of Physiology-Cell Physiology 296 (5), C980-C991, 2009
3292009
Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins
Y Xu, S Masuko, M Takieddin, H Xu, R Liu, J Jing, SA Mousa, RJ Linhardt, ...
Science 334 (6055), 498-501, 2011
3072011
Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions
OJT McCarty, SA Mousa, PF Bray, K Konstantopoulos
Blood, The Journal of the American Society of Hematology 96 (5), 1789-1797, 2000
2962000
Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise
DJ Bharali, SA Mousa
Pharmacology & therapeutics 128 (2), 324-335, 2010
2902010
Proangiogenic action of thyroid hormone is fibroblast growth factor–dependent and is initiated at the cell surface
FB Davis, SA Mousa, L O’Connor, S Mohamed, HY Lin, HJ Cao, PJ Davis
Circulation research 94 (11), 1500-1506, 2004
2832004
The system can't perform the operation now. Try again later.
Articles 1–20